"L'Hôpital privé Clairval, établissement du groupe Ramsay Santé, à Marseille accueille chaque année près de 32 000 patients au sein de ses pôles d'excellence. Les 150 médecins qui travaillent sur le site de cet établissement dispensent des soins de haute qualité dans le respect et l'écoute de chacun. Cet hôpital privé propose une offre de soins polyvalente et complète au sein de l'une des structures les plus importantes de la région Provence-Alpes-Côte d'azur."

During the past decade, Hôpital Privé Clairval conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé Clairval" #1 sponsor was "Ramsay Générale de Santé" with 5 trials, followed by "Biotronik SE & Co. KG" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "LivaNova" with 3 trials sponsored and "Medtronic" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé Clairval" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé Clairval" are "Heart Failure" (5 trials), "Intracranial Aneurysm" (3 trials), "Breast Cancer" (2 trials), "Cervical Discopathy" (2 trials) and "Glioma" (2 trials). Many other conditions were trialed in "Hôpital Privé Clairval" in a lesser frequency.

Most popular intervention types in "Hôpital Privé Clairval" are "Device" (23 trials), "Drug" (11 trials), "Other" (8 trials), "Procedure" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Abiraterone acetate (AA)" (1 trials), "Archival Tumor Tissue Sample" (1 trials), "Artefact IRM assessment" (1 trials) and "Atrial flutter ablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé Clairval" are 44 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 17 active trials in "Hôpital Privé Clairval". 1 are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Hôpital Privé Clairval, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé Clairval, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".